NYSE:TRV • US89417E1091
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TRAVELERS COS INC/THE (TRV).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-19 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2026-02-02 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2026-01-27 | Citigroup | Maintains | Sell -> Sell |
| 2026-01-23 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2026-01-23 | Roth Capital | Maintains | Buy -> Buy |
| 2026-01-22 | Mizuho | Maintains | Neutral -> Neutral |
| 2026-01-22 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-14 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2026-01-13 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-08 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-01-07 | JP Morgan | Maintains | Underweight -> Underweight |
| 2026-01-06 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-12-16 | Mizuho | Initiate | Neutral |
| 2025-11-17 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-20 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-10-17 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-17 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-09 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-10-08 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-08 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-07 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-09-16 | Wolfe Research | Initiate | Peer Perform |
| 2025-07-21 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-18 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 41.364B 12.03% | 46.423B 12.23% | 48.828B 5.18% | 45.516B -6.78% | 46.963B 3.18% | 48.845B 4.01% | 50.679B 3.75% | |
| EBITDA YoY % growth | 10.707B 6.18% | 14.27B 33.28% | 16.169B 13.31% | 9.164B -43.32% | 7.898B -13.81% | N/A | N/A | |
| EBIT YoY % growth | 3.759B 0.43% | 6.582B 75.10% | 8.223B 24.93% | 7.589B -7.71% | 7.516B -0.96% | 7.124B -5.22% | 6.757B -5.15% | |
| Operating Margin | 9.09% | 14.18% | 16.84% | 16.67% | 16.00% | 14.58% | 13.33% | |
| EPS YoY % growth | 12.23 -1.29% | 21.59 76.53% | 27.69 28.25% | 27.51 -0.66% | 28.62 4.05% | 28.89 0.93% | 25.26 -12.56% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 6.95 263.65% | 4.88 -25.05% | 6.10 -25.06% | 9.11 -18.12% | 7.29 4.93% | 5.35 9.62% | 6.39 4.76% | 9.67 6.11% |
| Revenue Q2Q % growth | 10.788B 2.60% | 11.814B 2.35% | 12.035B 4.90% | 11.376B 4.79% | 11.351B 5.22% | 12.571B 6.41% | 12.598B 4.68% | 12.05B 5.92% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 2.156B 278.91% | 1.387B -29.95% | 1.685B -31.36% | N/A | N/A | N/A | N/A | N/A |
All data in USD
31 analysts have analysed TRV and the average price target is 307.25 USD. This implies a price increase of 1.57% is expected in the next year compared to the current price of 302.49.
TRAVELERS COS INC/THE (TRV) will report earnings on 2026-04-14, before the market open.
The consensus EPS estimate for the next earnings of TRAVELERS COS INC/THE (TRV) is 6.95 USD and the consensus revenue estimate is 10.79B USD.
The consensus rating for TRAVELERS COS INC/THE (TRV) is 67.7419 / 100 . This indicates that analysts generally have a neutral outlook on the stock.